YAP1 and colorectal carcinoma: These compounds modulate the Hippo/YAP signaling pathway through a variety of mechanisms, including targeted YAP, autophagy regulation, mitochondrial dynamics, pathway inhibition, and metabolic reprogramming, demonstrating their potential to inhibit CRC cell proliferation and invasion (Table 4).